Is a complete OSL/TRMED research report available?

No complete published report is available for osl/TRMED (OSL/TRMED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

OSL/TRMED (OSL/TRMED)

Oslo Børs: OSL/TRMED · NOK

NOK 5.79

+1.27 (+28.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first OSL/TRMED analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.1B
Revenue (ttm)	839K
Net income (ttm)	-58M
EPS (ttm)	-NOK 0.17
Shares out	360M
Volume	0
Beta	-0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 839K
Net income (ttm): -58M
EPS (ttm): -NOK 0.17
Market cap: 2.1B

All OSL/TRMED indicators

Market & fundamental data

Available fields

162

Groups with data

Currency

NOK

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	18
Employees Change	9%
Employees Change Percent	100
Enterprise value	NOK 2.1B
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0010597883
Last refreshed	2026-08-02
Market cap	NOK 2.1B
Price	NOK 5.79
Price currency	NOK
Rev Per Employee	46,611.11x
Sector	Healthcare
Sic	2836
Symbol	osl/TRMED
Website	https://www.thormedical.no

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.78%
FCF yield	-5.79%
P/B ratio	4.57x
P/S ratio	2,484.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	NOK 839,000
Net Income	NOK -58M
Net Income Growth Years	0%
Pretax Margin	-7,421.69%
Profit Per Employee	NOK -3.2M
ROA	-7.75
ROCE	-10.47
ROE	-14.63
ROIC	-9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	133.6%
Cagr3y	50.92%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0
Assets	NOK 708.6M
Cash	NOK 180.6M
Current Assets	NOK 199.5M
Current Liabilities	NOK 43.7M
Debt	NOK 171.4M
Debt Equity	NOK 0.38
Debt FCF	NOK -1.42
Equity	NOK 456M
Interest Coverage	-115.7
Liabilities	NOK 252.6M
Long Term Assets	NOK 509.1M
Long Term Liabilities	NOK 209M
Net Cash	NOK 9.2M
Net Cash By Market Cap	NOK 0.44
Net Cash Growth	-92.52%
Net Debt Equity	NOK -0.02
Tangible Book Value	NOK 191.9M
Tangible Book Value Per Share	NOK 0.54
WACC	2.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.57
Net Working Capital	NOK -12.5M
Quick ratio	4.46
Working Capital	NOK 155.9M
Working Capital Turnover	NOK 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	133.47%
200-day SMA	4.41
3Y total return	243.86%
50-day SMA	4.34
50-day SMA vs 200-day SMA	50under200
All Time High	5.9
All Time High Change	-1.86%
All Time High Date	2026-07-31
All Time Low	0.85
All Time Low Change	581.18%
All Time Low Date	2024-03-06
ATR	0.22
Beta	-0.23
Beta1y	1.02
Beta2y	0.33
Ch YTD	10.29
High	5.9
High52	5.9
High52 Date	2026-07-31
High52ch	-0.17%
Low	4.65
Low52	2.34
Low52 Date	2025-08-14
Low52ch	147.44%
Ma50ch	33.53%
Price vs 200-day SMA	31.32%
RSI	86.31
RSI Monthly	71.01
RSI Weekly	67.58
Sharpe ratio	1.59x
Sortino ratio	2.78
Total Return	-40.8%
Tr YTD	10.29
Tr1m	35.44%
Tr1w	30.41%
Tr3m	30.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -69.7M
Operating margin	-8,301.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	151,307,147%
Net Borrowing	-1,078,000
Shares Insiders	8.68%
Shares Institutions	8.58%
Shares Out	360,001,820
Shares Qo Q	13.99%
Shares Yo Y	40.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -124.7M
Adjusted OCF	-51,547,000
Average Volume	1,605,850.85x
Bv Per Share	1.29
CAPEX	NOK -73.1M
Ch1m	35.44
Ch1w	30.41
Ch1y	133.5
Ch3m	30.85
Ch3y	235.8
Ch6m	19.26
Change	28.1%
Change From Open	24.38
Close	4.52
Days Gap	2.99
Depreciation Amortization	19,522,000
Earnings Date	2026-08-28
EBIT	NOK -69.7M
EBITDA	NOK -50.1M
EPS	NOK -0.17
F Score	1
FCF	NOK -120.6M
FCF EV Yield	-5.81x
FCF Per Share	NOK -0.34
Financing CF	171,186,000
Fiscal Year End	December
Founded	2,009
Goodwill	37,216,000
Income Tax	NOK -4.3M
Investing CF	-66,479,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	4.61
Ma150ch	25.65%
Ma20	4.42
Ma20ch	31.08%
Net CF	57,167,000
Next Earnings Date	2026-08-28
Open	4.66
Position In Range	91.2
Ppne	244,229,000
Price Date	2026-07-31
Ptbv Ratio	10.86
Relative Volume	17.36x
Revenue	839,000x
SBC By Revenue	477.59x
Share Based Comp	4,007,000
Tax By Revenue	-507.27x
Tr6m	19.26%
Volume	0
Z Score	2.06

OSL/TRMED (OSL/TRMED)

Coverage state: Market snapshot only — no published research

Generate the first OSL/TRMED analysis

Price

Financial snapshot

Fair-value bridge

Latest news · OSL/TRMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OSL/TRMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OSL/TRMED

Frequently asked questions